Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Suzy, Syrett"'
Autor:
Oliver Owrid, Leonie Richardson, Stephanie Allan, Amy Grant, Sarah Gogan, Nicholas Hamilton, Francis Yanga, Nicola Sirey, Suzy Syrett, Philippa Garety, Tom Craig, Moya Clancy, Vanessa Pinfold, Lucy Miller, Thomas Ward, Clementine Edwards
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract This article describes a Patient and Public Involvement (PPI) led creative workshop space held within a clinical trial of a talking therapy for distressing voices (AVATAR2). PPI adds significant value to clinical research and ensures the wor
Externí odkaz:
https://doaj.org/article/f2e97fb0b870497cae6f150f6274c630
Autor:
Rory C. O’Connor, Susie Smillie, Heather McClelland, Jenna-Marie Lundy, Corinna Stewart, Suzy Syrett, Marcela Gavigan, Alex McConnachie, Bethany Stanley, Michael Smith, Gregory K. Brown, Barbara Stanley, Sharon A. Simpson
Publikováno v:
Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-23 (2022)
Abstract Background A previous suicide attempt is an important predictor of future suicide. However, there are no evidence-based interventions administered in UK general hospital contexts to reduce suicidal behaviour in patients admitted following a
Externí odkaz:
https://doaj.org/article/e5b9ee1c4ceb4850826536bc03dc69a1
Autor:
Anthony P Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie, Jemma Hudson, Samantha Bowe, Paul French, Paul Hutton, Rory Byrne, Suzy Syrett, Robert Dudley, Hamish J McLeod, Helen Griffiths, Thomas RE Barnes, Linda Davies, Gemma Shields, Deborah Buck, Sarah Tully, David Kingdon
Publikováno v:
Health Technology Assessment, Vol 23, Iss 7 (2019)
Background: Clozapine (clozaril, Mylan Products Ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. However, a significant number of patients who trial clozapine have an inadeq
Externí odkaz:
https://doaj.org/article/9878216e8eb748928419e6fe983474a2
Publikováno v:
DCP-S Review. 1:27-29
Suzy Syrett, Stephanie Allan, Edel Mc Glanaghy and Jane-Louise Jacksonall represented Scotland, and their unique perspective on research, at a DCP-UK qualification event in August 2018. This event focused on the importance of research within clinical
Autor:
Alex McConnachie, Susie Smillie, Heather McClelland, Michael S. Smith, Gregory K. Brown, Suzy Syrett, Jenna-Marie Lundy, Rory C. O'Connor, Barbara Stanley, Daniel J. Smith, Marcela Gavigan, Corinna Stewart, Sharon Anne Simpson
Publikováno v:
BMJ Open
IntroductionThere are no evidence-based interventions that can be administered in hospital settings following a general hospital admission after a suicide attempt.AimTo determine whether a safety planning intervention (SPI) with follow-up telephone s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1eba079b0f30f3a6b23053b882924dd
https://strathprints.strath.ac.uk/77312/1/OConnor_etal_BMJO2019_SAFETEL_randomised_controlled_feasibility_trial_safety_planning_intervention_follow_up_telephone_contact_reduce_suicidal_behaviour.pdf
https://strathprints.strath.ac.uk/77312/1/OConnor_etal_BMJO2019_SAFETEL_randomised_controlled_feasibility_trial_safety_planning_intervention_follow_up_telephone_contact_reduce_suicidal_behaviour.pdf
Autor:
Anthony P, Morrison, Melissa, Pyle, Andrew, Gumley, Matthias, Schwannauer, Douglas, Turkington, Graeme, MacLennan, John, Norrie, Jemma, Hudson, Samantha E, Bowe, Paul, French, Rory, Byrne, Suzy, Syrett, Robert, Dudley, Hamish J, McLeod, Helen, Griffiths, Thomas R E, Barnes, Linda, Davies, David, Kingdon, Sarah, Tully
Publikováno v:
The lancet. Psychiatry. 5(8)
Although clozapine is the treatment of choice for treatment-refractory schizophrenia, 30-40% of patients have an insufficient response, and others are unable to tolerate it. Evidence for any augmentation strategies is scarce. We aimed to determine wh
Autor:
Anthony P. Morrison, Graeme MacLennan, Linda Davies, Matthias Schwannauer, Suzy Syrett, Helen Griffiths, Thomas R. E. Barnes, Andrew Gumley, Hamish J. McLeod, Rory Byrne, David Kingdon, Paul Hutton, John Norrie, Samantha Bowe, Robert Dudley, Melissa Pyle, Paul French, Douglas Turkington
Publikováno v:
BMC Psychiatry
Pyle, M, Norrie, J, Schwannauer, M, Kingdon, D, Gumley, A, Tarkington, D, Byrne, R, Syrett, S, MacLennan, G, Dudley, R, McLeod, H J, Griffiths, H, Bowe, S, Barnes, T R E, French, P, Hutton, P, Davies, L & Morrison, A P 2016, ' Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial : A randomised controlled trial ', BMC Psychiatry, vol. 16, no. 1, 280 . https://doi.org/10.1186/s12888-016-0983-6
Pyle, M, Norrie, J, Schwannauer, M, Kingdon, D, Gumley, A, Turkington, D, Byrne, R, Syrett, S, MacLennan, G, Dudley, R, McLeod, H J, Griffiths, H, Bowe, S, Barnes, T R E, French, P, Hutton, P, Davies, L & Morrison, A 2016, ' Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial : A randomised controlled trial ', BMC Psychiatry, vol. 16, no. 1, 280 . https://doi.org/10.1186/s12888-016-0983-6
Pyle, M, Norrie, J, Schwannauer, M, Kingdon, D, Gumley, A, Tarkington, D, Byrne, R, Syrett, S, MacLennan, G, Dudley, R, McLeod, H J, Griffiths, H, Bowe, S, Barnes, T R E, French, P, Hutton, P, Davies, L & Morrison, A P 2016, ' Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial : A randomised controlled trial ', BMC Psychiatry, vol. 16, no. 1, 280 . https://doi.org/10.1186/s12888-016-0983-6
Pyle, M, Norrie, J, Schwannauer, M, Kingdon, D, Gumley, A, Turkington, D, Byrne, R, Syrett, S, MacLennan, G, Dudley, R, McLeod, H J, Griffiths, H, Bowe, S, Barnes, T R E, French, P, Hutton, P, Davies, L & Morrison, A 2016, ' Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial : A randomised controlled trial ', BMC Psychiatry, vol. 16, no. 1, 280 . https://doi.org/10.1186/s12888-016-0983-6
Background: For around a third of people with a diagnosis of schizophrenia, the condition proves to respond poorly to treatment with many typical and atypical antipsychotics. This is commonly referred to as treatment-resistant schizophrenia. Clozapin